UK: Syncona companies combine to create Spur Therapeutics

Spur Therapeutics, formerly Freeline Therapeutics, has acquired SwanBio Therapeutics.The acquisition combines two of Syncona’s clinical-stage portfolio companies, representing a significant opportunity to deliver two first-in-class gene therapies and advance a […]